Literature DB >> 19821721

Cryptosporidium parvum infection rapidly induces a protective innate immune response involving type I interferon.

Farah M Barakat1, Vincent McDonald, Graham R Foster, Michael G Tovey, Daniel S Korbel.   

Abstract

Type II interferon (IFN), IFN-gamma, is important in innate immunity to the intestinal protozoan parasite Cryptosporidium species, which infects epithelial cells (enterocytes). This investigation is, to our knowledge, the first to characterize the role of type I IFN in innate immunity to this parasite. Pretreatment of human or murine enterocyte cell lines with IFN-alpha/beta inhibited parasite development, and we identified that a key mechanism of cytokine action was to prevent parasite invasion of enterocytes. IFN-alpha/beta was rapidly expressed by infected murine enterocytes and also by bone marrow-derived dendritic cells that were exposed to live parasites. Treatment of neonatal severe combined immunodeficiency mice with anti-IFN-alpha/beta neutralizing antibodies before infection increased oocyst reproduction, as measured at the peak of infection, and parasite numbers in gut epithelium were also increased 2 days after infection. The latter observation correlated with strong intestinal expression of both IFN-alpha and IFN-beta messenger RNA within 24 h after infection. Treatment with anti-IFN-alpha/beta, however, did not reduce early expression of IFN-gamma. These findings identify a novel early innate host response against Cryptosporidium parvum involving IFN-alpha/beta.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19821721     DOI: 10.1086/644601

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Systemic and Mucosal Immune Responses to Cryptosporidium-Vaccine Development.

Authors:  Jacob G Ludington; Honorine D Ward
Journal:  Curr Trop Med Rep       Date:  2015-09-01

2.  MicroRNA-221 controls expression of intercellular adhesion molecule-1 in epithelial cells in response to Cryptosporidium parvum infection.

Authors:  Ai-Yu Gong; Guoku Hu; Rui Zhou; Jun Liu; Yaoyu Feng; Garrett A Soukup; Xian-Ming Chen
Journal:  Int J Parasitol       Date:  2011-01-12       Impact factor: 3.981

3.  Cryptosporidiosis-an overview.

Authors:  Gordon J Leitch; Qing He
Journal:  J Biomed Res       Date:  2012-02-21

Review 4.  Parasites and malignancies, a review, with emphasis on digestive cancer induced by Cryptosporidium parvum (Alveolata: Apicomplexa).

Authors:  S Benamrouz; V Conseil; C Creusy; E Calderon; E Dei-Cas; G Certad
Journal:  Parasite       Date:  2012-02-01       Impact factor: 3.000

Review 5.  Prospects for immunotherapy and vaccines against Cryptosporidium.

Authors:  Jan R Mead
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

6.  Revisiting the global problem of cryptosporidiosis and recommendations.

Authors:  Arpit Kumar Shrivastava; Subrat Kumar; Woutrina A Smith; Priyadarshi Soumyaranjan Sahu
Journal:  Trop Parasitol       Date:  2017 Jan-Jun

Review 7.  Lessons Learned from Protective Immune Responses to Optimize Vaccines against Cryptosporidiosis.

Authors:  Maxime W Lemieux; Karine Sonzogni-Desautels; Momar Ndao
Journal:  Pathogens       Date:  2017-12-24

8.  Interferon-λ3 Promotes Epithelial Defense and Barrier Function Against Cryptosporidium parvum Infection.

Authors:  Sylvia H Ferguson; Derek M Foster; Barbara Sherry; Scott T Magness; Dahlia M Nielsen; Jody L Gookin
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-03-05

9.  A host cell long noncoding RNA NR_033736 regulates type I interferon-mediated gene transcription and modulates intestinal epithelial anti-Cryptosporidium defense.

Authors:  Juan Li; Kehua Jin; Min Li; Nicholas W Mathy; Ai-Yu Gong; Silu Deng; Gislaine A Martins; Mingfei Sun; Juliane K Strauss-Soukup; Xian-Ming Chen
Journal:  PLoS Pathog       Date:  2021-01-22       Impact factor: 6.823

10.  A rapid IL-17 response to Cryptosporidium parvum in the bovine intestine.

Authors:  Emma Drinkall; Matthew J Wass; Tracey J Coffey; Robin J Flynn
Journal:  Vet Immunol Immunopathol       Date:  2017-07-23       Impact factor: 2.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.